A cyclooxygenase-2-dependent prostaglandin e2 biosynthetic system in the Golgi apparatus

Journal of Biological Chemistry

Volumn 290, Issue 9, 2015, Pages 5606-5620

  Yuan, Chong ^a   Smith, William L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CELL MEMBRANES; ENZYME INHIBITION; ESTERIFICATION; GLYCOSYLATION; LIPIDS;

ARACHIDONIC ACIDS; CATALYTIC COUPLING; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE; DEDICATED SYSTEMS; ENDOPLASMIC RETICULUM; INNER MEMBRANES; NUCLEAR ENVELOPE;

BIOSYNTHESIS;

ARACHIDONIC ACID; ASPARAGINE; ASPARTIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2ALPHA; GLUTAMIC ACID; GLYCAN; LEUCINE; LYSINE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; UNCLASSIFIED DRUG; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; ISOMERASE; ISOQUINOLINE DERIVATIVE; LEUPEPTIN; N-(2-(4-BROMOCINNAMYLAMINO)ETHYL)-5-ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE A2 GROUP IV; PROSTAGLANDIN E SYNTHASE; PROTEIN KINASE INHIBITOR; SULFONAMIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL MIGRATION; CONFOCAL IMMUNOCYTOFLUORESCENCE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ER RETENTION SIGNAL; FLUORESCENCE; GLYCOSYLATION; GOLGI COMPLEX; GOLGI TARGETING SIGNAL; HUMAN; HUMAN CELL; KDEL SEQUENCE; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN TRANSPORT; STEL SEQUENCE; TIME; 3T3 CELL LINE; ANIMAL; BIOSYNTHESIS; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; HEK293 CELL LINE; IMMUNOBLOTTING; METABOLISM; MUTATION;

AMINO ACID SEQUENCE; ANIMALS; ASPARAGINE; CYCLOOXYGENASE 2; CYSTEINE PROTEINASE INHIBITORS; DINOPROSTONE; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM-ASSOCIATED DEGRADATION; FIBROBLASTS; GLYCOSYLATION; GOLGI APPARATUS; GROUP IV PHOSPHOLIPASES A2; HEK293 CELLS; HUMANS; IMMUNOBLOTTING; INTRAMOLECULAR OXIDOREDUCTASES; ISOQUINOLINES; LEUPEPTINS; MICE; MICROSCOPY, CONFOCAL; MUTATION; NIH 3T3 CELLS; PROTEIN KINASE INHIBITORS; PROTEIN TRANSPORT; SULFONAMIDES;

EID: 84923802325     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.632463     Document Type: Article

References (70)

1. Narumiya, S., and Furuyashiki, T. (2011) Fever, inflammation, pain and beyond: prostanoid receptor research during these 25 years. FASEB J. 25, 813-818
2. Majed, B. H., and Khalil, R. A. (2012) Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol. Rev. 64, 540-582
3. Patrono, C., García Rodríguez, L. A., Landolfi, R., and Baigent, C. (2005) Low-dose aspirin for the prevention of atherothrombosis. N. Engl. J. Med. 353, 2373-2383
4. Yu, Y., Ricciotti, E., Scalia, R., Tang, S. Y., Grant, G., Yu, Z., Landesberg, G., Crichton, I., Wu, W., Puré, E., Funk, C. D., and FitzGerald, G. A. (2012) Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci. Transl. Med. 4, 132ra54
5. 5. Schneider, C., Pratt, D. A., Porter, N. A., and Brash, A. R. (2007) Control of oxygenation in lipoxygenase and cyclooxygenase catalysis. Chem. Biol. 14, 473-488
6. Tsai, A. L., and Kulmacz, R. J. (2010) Prostaglandin H synthase: resolved and unresolved mechanistic issues. Arch. Biochem. Biophys. 493, 103-124
7. Smith, W. L., Urade, Y., and Jakobsson, P. J. (2011) Enzymes of the cyclooxygenase pathways of prostanoid biosynthesis. Chem. Rev. 111, 5821-5865
8. Leslie, C. C., Gangelhoff, T. A., and Gelb, M. H. (2010) Localization and function of cytosolic phospholipase A2α at the Golgi. Biochimie 92, 620-626
9. Murakami, M., Taketomi, Y., Sato, H., and Yamamoto, K. (2011) Secreted phospholipase A2 revisited. J. Biochem. 150, 233-255
10. Dennis, E. A., Cao, J., Hsu, Y. H., Magrioti, V., and Kokotos, G. (2011) Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem. Rev. 111, 6130-6185
11. Kulmacz, R. J., and Lands, W. E. (1984) ProstaglandinHsynthase. Stoichiometry of heme cofactor. J. Biol. Chem. 259, 6358-6363
12. Prusakiewicz, J. J., Duggan, K. C., Rouzer, C. A., and Marnett, L. J. (2009) Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid. Biochemistry 48, 7353-7355
13. Vecchio, A. J., Simmons, D. M., and Malkowski, M. G. (2010) Structural basis of fatty acid substrate binding to cyclooxygenase-2. J. Biol. Chem. 285, 22152-22163
14. Dong, L., Vecchio, A. J., Sharma, N. P., Jurban, B. J., Malkowski, M. G., and Smith, W. L. (2011) Human cyclooxygenase-2 Is a sequence homodimer that functions as a conformational heterodimer. J. Biol. Chem. 286, 19035-19046
15. Zou, H., Yuan, C., Dong, L., Sidhu, R. S., Hong, Y. H., Kuklev, D. V., and Smith, W. L. (2012) Human cyclooxygenase-1 activity and its responses to COX inhibitors are allosterically regulated by nonsubstrate fatty acids. J. Lipid Res. 53, 1336-1347
16. Dong, L., Sharma, N. P., Jurban, B. J., and Smith, W. L. (2013) Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer. J. Biol. Chem. 288, 28641-28655
17. Yuan, C., Sidhu, R. S., Kuklev, D. V., Kado, Y., Wada, M., Song, I., and Smith, W. L. (2009) Cyclooxygenase allosterism, fatty acid-mediated cross-talk between monomers of cyclooxygenase homodimers. J. Biol. Chem. 284, 10046-10055
18. Picot, D., Loll, P. J., and Garavito, R. M. (1994) The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 367, 243-249
19. Rollins, T. E., and Smith, W. L. (1980) Subcellular localization of prosta-glandin-forming cyclooxygenase in Swiss mouse 3T3 fibroblasts by electron microscopic immunocytochemistry. J. Biol. Chem. 255, 4872-4875
20. Otto, J. C., and Smith, W. L. (1994) The orientation of prostaglandin endoperoxide synthases-1 and -2 in the endoplasmic reticulum. J. Biol. Chem. 269, 19868-19875
21. Otto, J. C., and Smith, W. L. (1996) Photolabeling of prostaglandin endoperoxide H synthase-1 with 3-trifluoro-3-(m-[125I]iodophenyl)diazirine as a probe of membrane association and the cyclooxygenase active site. J. Biol. Chem. 271, 9906-9910
22. Spencer, A. G., Woods, J. W., Arakawa, T., Singer, I. I., and Smith, W. L. (1998) Subcellular localization of prostaglandin endoperoxide H syn-thases-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273, 9886-9893
23. Spencer, A. G., Thuresson, E., Otto, J. C., Song, I., Smith, T., DeWitt, D. L., Garavito, R. M., and Smith, W. L. (1999) The membrane binding domains of prostaglandin endoperoxideHsynthase-1 and -2: peptide mapping and mutational analysis. J. Biol. Chem. 274, 32936-32942
24. Morita, I., Schindler, M., Regier, M. K., Otto, J. C., Hori, T., DeWitt, D. L., and Smith, W. L. (1995) Different intracellular locations for prostaglandin endoperoxide H synthases-1 and -2. J. Biol. Chem. 270, 10902-10908
25. Kang, Y. J., Mbonye, U. R., DeLong, C. J., Wada, M., and Smith, W. L. (2007) Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog. Lipid Res. 46, 108-125
26. Järving, R., Järving, I., Kurg, R., Brash, A. R., and Samel, N. (2004) On the evolutionary origin of cyclooxygenase (COX) isozymes: characterization of marine invertebrate COX genes points to independent duplication events in vertebrate and invertebrate lineages. J. Biol. Chem. 279, 13624-13633
27. Varvas, K., Kurg, R., Hansen, K., Järving, R., Järving, I., Valmsen, K., Lõhelaid, H., and Samel, N. (2009) Direct evidence of the cyclooxygenase pathway of prostaglandin synthesis in arthropods: genetic and biochemical characterization of two crustacean cyclooxygenases. Insect Biochem. Mol. Biol. 39, 851-860
28. Mbonye, U. R., Wada, M., Rieke, C. J., Tang, H.-Y., Dewitt, D. L., and Smith, W. L. (2006) The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system. J. Biol. Chem. 281, 35770-35778
29. Mbonye, U. R., Yuan, C., Harris, C. E., Sidhu, R. S., Song, I., Arakawa, T., and Smith, W. L. (2008) Two distinct pathways for cyclooxygenase-2 protein degradation. J. Biol. Chem. 283, 8611-8623
30. Wada, M., Saunders, T. L., Morrow, J., Milne, G. L., Walker, K. P., Dey, S. K., Brock, T. G., Opp, M. R., Aronoff, D. M., and Smith, W. L. (2009) Two pathways for cyclooxygenase-2 protein degradation in vivo. J. Biol. Chem. 284, 30742-30753
31. Smith, W. L. (1986) Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu. Rev. Physiol. 48, 251-262
32. Haddad, A., Flint-Ashtamker, G., Minzel, W., Sood, R., Rimon, G., and Barki-Harrington, L. (2012) Prostaglandin EP1 receptor down-regulates expression of cyclooxygenase-2 by facilitating Its proteasomal degradation. J. Biol. Chem. 287, 17214-17223
33. Uddin, M. J., Crews, B. C., Blobaum, A. L., Kingsley, P. J., Gorden, D. L., McIntyre, J. O., Matrisian, L. M., Subbaramaiah, K., Dannenberg, A. J., Piston, D. W., and Marnett, L. J. (2010) Selective visualization of cyclooxy-genase-2 in inflammation and cancer by targeted fluorescent imaging agents. Cancer Res. 70, 3618-3627
34. Hou, Z., Falcone, D. J., Subbaramaiah, K., and Dannenberg, A. J. (2011) Macrophages induce COX-2 expression in breast cancer cells: role of IL-1β autoamplification. Carcinogenesis 32, 695-702
35. Chen, S.-F., Wu, C.-H., Lee, Y.-M., Tam, K., Tsai, Y.-C., Liou, J.-Y., and Shyue, S.-K. (2013) Caveolin-1 interacts with derlin-1 and promotes ubiquitination and degradation of cyclooxygenase-2 via collaboration with p97 complex. J. Biol. Chem. 288, 33462-33469
36. Dancourt, J., and Barlowe, C. (2010) Protein sorting receptors in the early secretory pathway. Annu. Rev. Biochem. 79, 777-802
37. Hoseki, J., Ushioda, R., and Nagata, K. (2010) Mechanism and components of endoplasmic reticulum-associated degradation. J. Biochem. 147, 19-25
38. Hosokawa, N., Kamiya, Y., and Kato, K. (2010) The role of MRH domaincontaining lectins in ERAD. Glycobiology 20, 651-660
39. Smith, M. H., Ploegh, H. L., and Weissman, J. S. (2011) Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 334, 1086-1090
40. Guerriero, C. J., and Brodsky, J. L. (2012) The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol. Rev. 92, 537-576
41. Liao, W.-L., Wang, W.-C., Chang, W.-C., and Tseng, J. T. (2011) The RNA-binding protein HuR stabilizes cytosolic phospholipase A2α mRNA under interleukin-1β treatment in non-small cell lung cancer A549 cells. J. Biol. Chem. 286, 35499-35508
42. Otto, J. C., DeWitt, D. L., and Smith, W. L. (1993) N-Glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem. 268, 18234-18242
43. Pan, S., Wang, S., Utama, B., Huang, L., Blok, N., Estes, M. K., Moremen, K. W., and Sifers, R. N. (2011) Golgi localization of ERManI defines spatial separation of the mammalian glycoprotein quality control system. Mol. Biol. Cell 22, 2810-2822
44. Ushioda, R., Hoseki, J., and Nagata, K. (2013) Glycosylation-independent ERAD pathway serves as a backup system under ER stress. Mol. Biol. Cell 24, 3155-3163
45. Raykhel, I., Alanen, H., Salo, K., Jurvansuu, J., Nguyen, V. D., Latva-Ranta, M., and Ruddock, L. (2007) A molecular specificity code for the three mammalian KDEL receptors. J. Cell Biol. 179, 1193-1204
46. Evans, J. H., and Leslie, C. C. (2004) The cytosolic phospholipase A2 catalytic domain modulates association and residence time at Golgi membranes. J. Biol. Chem. 279, 6005-6016
47. Hellen, C. U., and Sarnow, P. (2001) Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15, 1593-1612
48. Heifetz, A., Keenan, R. W., and Elbein, A. D. (1979) Mechanism of action of tunicamycin on the UDP-GlcNAc:dolichyl-phosphate Glc-NAc-1-phosphate transferase. Biochemistry 18, 2186-2192
49. Qasba, P. K., Ramakrishnan, B., and Boeggeman, E. (2008) Structure and function of β-1,4-galactosyltransferase. Curr. Drug Targets 9, 292-309
50. Lee, M. C., Miller, E. A., Goldberg, J., Orci, L., and Schekman, R. (2004) Bi-directional protein transport between the ER and Golgi. Annu. Rev. Cell Dev. Biol. 20, 87-123
51. Lochner, A., and Moolman, J. (2006) The many faces of H89: a review. Cardiovasc. Drug Rev. 24, 261-274
52. Blum, R., Pfeiffer, F., Feick, P., Nastainczyk, W., Kohler, B., Schäfer, K., and Schulz, I. (1999) Intracellular localization and in vivo trafficking of p24A and p23. J. Cell Sci. 112, 537-548
53. Wang, X., Matteson, J., An, Y., Moyer, B., Yoo, J.-S., Bannykh, S., Wilson, I. A., Riordan, J. R., and Balch, W. E. (2004) COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code. J. Cell Biol. 167, 65-74
54. Reddy, S. T., and Herschman, H. R. (1994) Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages. J. Biol. Chem. 269, 15473-15480
55. Lilley, B. N., and Ploegh, H. L. (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429, 834-840
56. Theesfeld, C. L., and Hampton, R. Y. (2013) Insulin-induced gene protein (INSIG)-dependent sterol regulation of Hmg2 endoplasmic reticulumassociated degradation (ERAD) in yeast. J. Biol. Chem. 288, 8519-8530
57. Elsabrouty, R., Jo, Y., Dinh, T. T., and DeBose-Boyd, R. A. (2013) Sterolinduced dislocation of 3-hydroxy-3-methylglutaryl coenzymeAreductase from membranes of permeabilized cells. Mol. Biol. Cell 24, 3300-3308
58. Appenzeller-Herzog, C., Nyfeler, B., Burkhard, P., Santamaria, I., Lopez-Otin, C., and Hauri, H.-P. (2005) Carbohydrate- and conformation-dependent cargo capture for ER-exit. Mol. Biol. Cell 16, 1258-1267
59. Kamiya, Y., Kamiya, D., Yamamoto, K., Nyfeler, B., Hauri, H.-P., and Kato, K. (2008) Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36. J. Biol. Chem. 283, 1857-1861
60. Kawasaki, N., Ichikawa, Y., Matsuo, I., Totani, K., Matsumoto, N., Ito, Y., and Yamamoto, K. (2008) The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2. Blood 111, 1972-1979
61. Chen, Y., Hojo, S., Matsumoto, N., and Yamamoto, K. (2013) Regulation of Mac-2BP secretion is mediated by its N-glycan binding to ERGIC-53. Glycobiology 23, 904-916
62. Zhang, H., Fan, J., Wang, J., Zhang, S., Dou, B., and Peng, X. (2013) An off-on COX-2-specific fluorescent probe: targeting the Golgi apparatus of cancer cells. J. Am. Chem. Soc. 135, 11663-11669
63. Bhattacharyya, D. K., Lecomte, M., Dunn, J., Morgans, D. J., and Smith, W. L. (1995) Selective inhibition of prostaglandin endoperoxide syn-thase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch. Biochem. Bio-phys. 317, 19-24
64. Shitashige, M., Morita, I., and Murota, S. (1998) Different substrate utilization between prostaglandin endoperoxide H synthase-1 and -2 in NIH3T3 fibroblasts. Biochim. Biophys. Acta 1389, 57-66
65. Liou, J.-Y., Deng, W.-G., Gilroy, D. W., Shyue, S.-K., and Wu, K. K. (2001) Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J. Biol. Chem. 276, 34975-34982
66. Dvorak, A. M., Morgan, E., Schleimer, R. P., Ryeom, S. W., Lichtenstein, L. M., and Weller, P. F. (1992) Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-mem-brane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J. Histochem. Cytochem. 40, 759-769
67. Murakami, M., Kambe, T., Shimbara, S., and Kudo, I. (1999) Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274, 3103-3115
68. Kojima, F., Naraba, H., Miyamoto, S., Beppu, M., Aoki, H., and Kawai, S. (2004) Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res. Ther. 6, R355-365
69. Murakami, M., Taketomi, Y., Miki, Y., Sato, H., Hirabayashi, T., and Yamamoto, K. (2011) Recent progress in phospholipase A2 research: from cells to animals to humans. Prog. Lipid Res. 50, 152-192
70. Schievella, A. R., Regier, M. K., Smith, W. L., and Lin, L. L. (1995) Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 270, 30749-30754